We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to ...
Zacks.com on MSN1d
Beat the Market the Zacks Way: Amgen, DRDGOLD, Anavex in FocusOur time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key ...
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
Zacks Investment Research on MSN2h
Amgen Rises Almost 22% YTD: Should You Buy, Hold or Sell the Stock?Amgen expects key drugs like Repatha, Evenity, Tezspire and oncology and rare disease drugs, as well as biosimilars to drive ...
The more we extend our horizon, the more likely it is that stocks will provide juicy returns. Investors can cash in by putting their money in exchange-traded funds (ETFs) that track the performance of ...
At least three new startups have already been launched out of the fund: U.K.-based Forth Therapeutics, French biotech ...
The appeals court for the Federal Circuit upheld a lower court’s ruling, finding that Regeneron has not sufficiently ...
The general mood among these heavyweight investors is divided, with 70% leaning bullish and 20% bearish. Among these notable ...
The phase 3 MINT trial evaluated the efficacy and safety of the drug in both muscle-specific kinase autoantibody ...
On March 14, 2025, the U.S. Court of Appeals for the Federal Circuit affirmed the District Court for the Northern District of West Virginia’s ...
After raising an impressive 1.2 billion euros in 2024, European venture capital firm Sofinnova Partners is topping up its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback